The effectiveness of Franseen needle for diagnosing malignant lymphoma

The effectiveness of Franseen needle for diagnosing malignant lymphoma - The effectiveness of Franseen needle for diagnosing malignant lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046873

Enrollment

150

Registered

2022-04-01

Start date

2022-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant lymphoma with mediastinal or abdominal lymphadenopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: >20-years-old EUS-FNA performed on mediastinal or abdominal lymph nodes for the diagnosis of malignant lymphoma

Exclusion criteria

Exclusion criteria: The patients who are otherwise judged by the investigator to be ineligible to participate in the study.

Design outcomes

Primary

Measure	Time frame
Diagnostic performance of each puncture needle for malignant lymphoma	—

Secondary

Measure	Time frame
7AAD analysis results for each puncture needle G-Band results for each needle FISH results for each needle Adverse event for each needle	—

Countries

Japan

Contacts

Public ContactMitsuru Okuno

Gifu municipal hospital Department of Gastroenterology

mkobdkl@yahoo.co.jp0582511101

Outcome results